Advanz, Morningside, Alliance accused of illegal market sharing
The CMA alleges that Alliance Healthcare bought equal volumes of nitrofurantoin from the companies to discourage competing.
Read More
Tag: Morningside
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
